Resonant Sensors
Private Company
Funding information not available
Overview
Resonant Sensors is a private biotechnology tools company commercializing a novel label-free biosensor platform for biologics discovery. Its core technology, guided-mode resonance (GMR), is embedded in disposable 96-well plates, allowing researchers to run 96 samples in parallel with small volumes to rapidly obtain kinetic binding data. The company targets the high-growth antibody discovery and characterization market, offering both its ResoSens instrument/consumables and related contract services through its affiliate, RSI Bioservices. Positioned as a benchtop alternative to traditional, more complex biosensor systems, Resonant Sensors aims to bring kinetic decision-making directly to discovery teams.
Technology Platform
Guided-Mode Resonance (GMR) photonic biosensor technology embedded in 96-well plates for label-free, real-time biomolecular interaction analysis and kinetic binding measurements.
Opportunities
Risk Factors
Competitive Landscape
Resonant Sensors competes in the label-free biosensor market against established giants like Cytiva (Biacore SPR systems) and Sartorius (Octet BLI systems). Its primary competitive differentiation is the 96-well parallel processing format and benchtop design, targeting higher throughput and easier accessibility than traditional SPR, while aiming to provide richer kinetic data than some BLI applications. It also competes with other plate-based screening methods (e.g., ELISA) by offering label-free, kinetic data.